Format

Send to

Choose Destination
Nat Rev Cancer. 2001 Nov;1(2):118-29.

Improving the efficacy of antibody-based cancer therapies.

Author information

1
Immunex, Seattle, Washington 98101, USA. carterp@immunex.com

Abstract

A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies.

PMID:
11905803
DOI:
10.1038/35101072
[Indexed for MEDLINE]

Publication type, MeSH terms, Substances

Publication type

MeSH terms

Substances

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center